Department of HPB and Liver Transplantation Surgery, Queen Elizabeth Hospital, Edgbaston, Birmingham, B15 2TH, UK.
Department of Surgery, Division of Surgical Oncology, The Ohio State University, Wexner Medical Centre, Columbus, OH, USA.
J Gastrointest Surg. 2018 Sep;22(9):1652-1658. doi: 10.1007/s11605-018-3825-7. Epub 2018 Jun 4.
Duodenal neuroendocrine tumours (dNETs) comprise about 2% of all the NETs. Treatment of dNETs involves resection of the tumour either by endoscopic or surgical resection. Surgical or endoscopic local resection of the lesion is usually a more conservative and less morbid option compared with a more radical pancreaticoduodenectomy. However, inadequate clearance by local resection might result in recurrent disease with reduced overall survival.
The current systematic review compared the differences in outcomes of endoscopic resection (ER), local resection (LR) and pancreaticoduodenectomy (PD) in the management of dNETs. Searches were performed on MEDLINE, PubMed, Embase and Cochrane databases using MeSH keyword combinations: 'duodenal', AND, 'neuroendocrine tumours'. All relevant articles published up to 2016 were included. Post-operative morbidity, R0 resection status and recurrence rates were the outcomes assessed.
Eight non-randomised retrospective studies with 335 participants were included (LR = 122; PD = 118; ER = 64). While PD was associated with higher morbidity compared with LR (27/64 vs. 10/74; P = 0.002), PD was associated with a higher incidence of an R0 resection (3/97 vs. 15/97; P = 0.007) as well as lower recurrence rates (3/51 vs. 6/46; P = 0.21). ER was associated with a higher positive resection margin status versus LR (22/51 vs. 14/91; P = 0.0002). Recurrence at follow-up was not different among patients with dNETs who underwent PD versus LR.
Radical surgical resection in the form of PD was associated with higher post-operative morbidity among patients with dNETs yet provided better margin clearance. Patients with dNETs need systematic evaluation with a view to obtain most of the information about the prognostic factors in order to tailor the treatment options.
十二指肠神经内分泌肿瘤(dNET)约占所有 NET 的 2%。dNET 的治疗包括通过内镜或手术切除肿瘤。与更激进的胰十二指肠切除术相比,手术或内镜下局部切除病变通常是一种更保守、更少病态的选择。然而,局部切除不充分可能导致疾病复发,总生存率降低。
本系统评价比较了内镜下切除(ER)、局部切除(LR)和胰十二指肠切除术(PD)在 dNET 治疗中的差异。在 MEDLINE、PubMed、Embase 和 Cochrane 数据库中使用 MeSH 关键词组合进行了搜索:“十二指肠”和“神经内分泌肿瘤”。纳入了截至 2016 年发表的所有相关文章。评估的结果是术后发病率、R0 切除状态和复发率。
纳入了 8 项非随机回顾性研究,共 335 名患者(LR=122;PD=118;ER=64)。与 LR 相比,PD 与更高的发病率相关(27/64 与 10/74;P=0.002),但 PD 与更高的 R0 切除率相关(3/97 与 15/97;P=0.007)以及更低的复发率(3/51 与 6/46;P=0.21)。与 LR 相比,ER 与更高的阳性切缘状态相关(22/51 与 14/91;P=0.0002)。在接受 PD 与 LR 治疗的 dNET 患者中,随访时的复发率无差异。
在 dNET 患者中,以 PD 为形式的根治性手术切除与更高的术后发病率相关,但提供了更好的切缘清除率。dNET 患者需要进行系统评估,以便获取有关预后因素的大部分信息,从而定制治疗方案。